<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962779</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22269</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Genet.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-0056</issn>
<issn pub-type="epub">1471-0064</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29479082</article-id>
<article-id pub-id-type="pmc">5990367</article-id>
<article-id pub-id-type="doi">10.1038/nrg.2018.4</article-id>
<article-id pub-id-type="manuscript">NIHMS970197</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrative omics for health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Karczewski</surname>
<given-names>Konrad J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<!--<email>konradjkarczewski@gmail.com</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snyder</surname>
<given-names>Michael P.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<!--<email>mpsnyder@stanford.edu</email>-->
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Massachusetts General Hospital, Boston, MA, USA</aff>
<aff id="A2">
<label>2</label>The Broad Institute of Harvard and MIT, Cambridge, MA, USA</aff>
<aff id="A3">
<label>3</label>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA</aff>
<author-notes>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare competing interests. See Web version for details.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>19</volume>
<issue>5</issue>
<fpage>299</fpage>
<lpage>310</lpage>
<!--elocation-id from pubmed: 10.1038/nrg.2018.4-->
<abstract>
<p id="P1">Advances in omics technologies — such as genomics, transcriptomics, proteomics and metabolomics — have begun to enable personalized medicine at an extraordinarily detailed molecular level. Individually, these technologies have contributed medical advances that have begun to enter clinical practice. However, each technology individually cannot capture the entire biological complexity of most human diseases. Integration of multiple technologies has emerged as an approach to provide a more comprehensive view of biology and disease. In this Review, we discuss the potential for combining diverse types of data and the utility of this approach in human health and disease. We provide examples of data integration to understand, diagnose and inform treatment of diseases, including rare and common diseases as well as cancer and transplant biology. Finally, we discuss technical and other challenges to clinical implementation of integrative omics.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>